Advertisement

Topics

Research identifies how master regulator, bone-building protein can be used for therapy

02:00 EDT 21 Jun 2017 | Medical Xpress

The WNT1 ligand has previously been identified in bone disease, but its role in bone homeostasis, its cellular source and targets in bone have only just recently been identified. The research, led by Dr. Brendan Lee at Baylor College of Medicine, appears in the Journal of Clinical Investigation.

Original Article: Research identifies how master regulator, bone-building protein can be used for therapy

NEXT ARTICLE

More From BioPortfolio on "Research identifies how master regulator, bone-building protein can be used for therapy"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Osteoporosis
Osteoporosis is a disease in which the bones become extremely porous, are subject to fracture, and heal slowly, occurring especially in women following menopause and often leading to curvature of the spine from vertebral collapse. Follow and track&n...